These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 2737171

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of phenylketonuria. Remarks on 21 cases].
    Farriaux JP, Desombre-Denys D, Charles-Bassi MA, Dhondt JL.
    Ann Pediatr (Paris); 1980 May; 27(5):291-5. PubMed ID: 7235512
    [No Abstract] [Full Text] [Related]

  • 25. [Phenylketonuria: contribution of clinical psychology to the overall comprehension of the disease].
    Rapoport D, Richardet JM.
    Rev Neuropsychiatr Infant; 1975 Feb; 23(2):111-27. PubMed ID: 1096267
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phenylketonuria: implications of initial serum phenylalanine levels on cognitive development.
    Barclay A, Walton O.
    Psychol Rep; 1988 Aug; 63(1):135-42. PubMed ID: 3212113
    [No Abstract] [Full Text] [Related]

  • 28. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP, Plüss C, Triaca H, Schütz B, Kaufmann R, Scherz R, Bachmann C, Zuppinger K.
    Schweiz Med Wochenschr; 1988 Jan 23; 118(3):94-9. PubMed ID: 3344414
    [Abstract] [Full Text] [Related]

  • 29. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C, Hanley WB, Rudner HL.
    Can Med Assoc J; 1984 Oct 01; 131(7):751-5. PubMed ID: 6478363
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comments on neuropsychological approaches to treatment policy issues in phenylketonuria.
    Stemerdink NB.
    Eur J Pediatr; 2000 Oct 01; 159 Suppl 2():S87-8. PubMed ID: 11221747
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet.
    Hackney IM, Hanley WB, Davidson W, Lindsao L.
    J Pediatr; 1968 May 01; 72(5):646-55. PubMed ID: 4171484
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of phenylketonuria.
    Levy HL.
    Prog Clin Biol Res; 1979 May 01; 34():171-82. PubMed ID: 531051
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.